Demant A/S (DEMANT.CO)
- Previous Close
266.20 - Open
267.00 - Bid 263.60 x --
- Ask 263.60 x --
- Day's Range
260.20 - 267.00 - 52 Week Range
202.40 - 350.00 - Volume
228,277 - Avg. Volume
271,073 - Market Cap (intraday)
56.15B - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
19.80 - EPS (TTM)
13.31 - Earnings Date Aug 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 26, 2000
- 1y Target Est
284.33
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
www.demant.comRecent News: DEMANT.CO
View MorePerformance Overview: DEMANT.CO
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DEMANT.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DEMANT.CO
View MoreValuation Measures
Market Cap
56.70B
Enterprise Value
71.27B
Trailing P/E
20.00
Forward P/E
19.61
PEG Ratio (5yr expected)
0.94
Price/Sales (ttm)
2.58
Price/Book (mrq)
5.93
Enterprise Value/Revenue
3.18
Enterprise Value/EBITDA
12.28
Financial Highlights
Profitability and Income Statement
Profit Margin
10.65%
Return on Assets (ttm)
8.66%
Return on Equity (ttm)
30.47%
Revenue (ttm)
22.42B
Net Income Avi to Common (ttm)
2.89B
Diluted EPS (ttm)
13.31
Balance Sheet and Cash Flow
Total Cash (mrq)
1.11B
Total Debt/Equity (mrq)
162.60%
Levered Free Cash Flow (ttm)
2.81B